ALPMY

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)

About ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Details

Daily high

$14.88

Daily low

$14.65

Price at open

$14.82

52 Week High

$16.95

52 Week Low

$8.37

Market cap

26.3B

Dividend yield

3.47%

Volume

121,273

Avg. volume

165,882

P/E ratio

12.19

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. News